Orbimag 300 (Magnesium Oxide)

Magnesium oxide, the active ingredient in Orbimag 300, is a mineral supplement presented as a 300 mg oral tablet for adult use. It treats magnesium deficiency, supports antacid therapy, and can be used as a laxative for occasional constipation. GNH USA supplies Orbimag 300 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orbimag 300 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orbimag 300 is a magnesium supplement that addresses conditions related to low magnesium levels or excess gastric acidity.

- Magnesium deficiency: helps restore normal serum magnesium concentrations. - Hypomagnesemia: supports correction of clinically low magnesium values. - Antacid therapy: neutralises excess stomach acid to relieve heartburn and dyspepsia. - Occasional constipation: increases intestinal water content to facilitate bowel movements.

Orbimag 300 may cause unwanted physiological responses, most of which are mild and transient.

Common Side Effects: - Diarrhoea: loose stools occurring after ingestion. - Abdominal cramping: mild to moderate stomach discomfort. - Nausea: feeling of queasiness without vomiting. - Flatulence: increased intestinal gas. - Metallic taste: temporary alteration in mouthfeel.

Serious or Rare Side Effects: - Hypermagnesemia: elevated blood magnesium levels that may cause cardiac rhythm changes. - Severe abdominal pain: persistent pain requiring medical evaluation. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Electrolyte imbalance: disturbances in calcium or potassium levels. - Persistent vomiting: ongoing emesis that leads to dehydration.

Before using Orbimag 300, consider the following safety measures.

- Renal impairment: dose may need adjustment or avoidance in severe kidney disease. - Cardiac conditions: monitor if patient has heart block or arrhythmias. - Drug interactions: review concomitant medications that affect magnesium levels. - Pregnancy and lactation: use only if clearly indicated by a healthcare professional. - Storage: Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Orbimag 300 can affect the absorption or activity of several medicines. Review the following interaction categories.

Major Interactions (Avoid): - Tetracycline antibiotics: reduced absorption of the antibiotic. - Bisphosphonates: magnesium may decrease drug bioavailability. - Potassium‑sparing diuretics: risk of additive hypermagnesemia.\nModerate Interactions (Monitor Closely): - Calcium supplements: competition for intestinal absorption. - Proton pump inhibitors: may alter magnesium homeostasis. - ACE inhibitors: potential for enhanced hypotensive effect.